The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo

Published:1995-10 Issue:10 Volume:1 Page:1052-1056
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Yang Zhi-Yong,Perkins Neil D.,Ohno Takeshi,Nabel Elizabeth G.,Nabel Gary J.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1095-1052.pdf

Reference44 articles.

1. King, R.W., Jackson, P.K. & Kirschner, M.W. Mitosis in transition. Cell 79, 563–571 (1994).

2. Heichman, K.A. & Roberts, J.M. Rules to replicate by. Cell 79, 557–562 (1994).

3. Sherr, C.J. G1 phase progression: Cycling on cue. Cell 79, 551–555 (1994).

4. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell 79, 547–550 (1994).

5. Hunter, T. & Pines, J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium valproate affects the expression of p16^INK4a and p21^WAFI/Cip1 cyclin‑dependent kinase inhibitors in HeLa cells;Oncology Letters;2024-07-11

2. Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen;ACS Chemical Biology;2023-04-25

3. Design, synthesis, and biological activities of 3-((4,6-diphenylpyrimidin-2-ylamino)methylene)-2,3-dihydrochromen-4-ones;Bioorganic Chemistry;2022-03

4. Epigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells;Current Molecular Pharmacology;2021-08

5. The Synergic Cytotoxicity Effect of Cisplatin and Salicylic Acid on the A2780 cp Ovarian Carcinoma Cell Line, and the Evaluation of p21 and ZEB1 Expression Levels;Indian Journal of Gynecologic Oncology;2021-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3